Sudeep Pharma Limited (NSE:SUDEEPPHRM)

India · Delayed Price · Currency is INR

606.95

-20.40 (-3.25%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003
Pharmaceutical, Food and Nutrition	3.30B	3.11B	3.30B	2.87B	-
Pharmaceutical, Food and Nutrition Growth	6.39%	-5.90%	14.89%	-	-
Specialty Ingredients	1.72B	1.49B	985.88M	572.51M	-
Specialty Ingredients Growth	15.40%	50.75%	72.20%	-	-
Specialty Chemicals	-	-	-	-	67.58M
Specialty Chemicals Growth	-	-	-	-	-5.85%
Total	5.02B	4.59B	4.29B	3.45B	67.58M
Total Growth	9.30%	7.12%	24.41%	4999.06%	-5.85%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003
Asia-Pacific	-	-	734.16M	537.90M	-
Asia-Pacific Growth	-	-	36.49%	-	-
Europe	-	-	663.85M	516.72M	-
Europe Growth	-	-	28.47%	-	-
India	2.04B	1.63B	1.35B	1.16B	67.58M
India Growth	25.14%	20.77%	16.78%	1614.13%	-5.85%
Middle East and Africa	-	-	237.15M	240.53M	-
Middle East and Africa Growth	-	-	-1.41%	-	-
Others	2.02B	1.93B	238.50M	139.65M	-
Others Growth	4.96%	708.35%	70.78%	-	-
United States of America	951.81M	1.03B	1.06B	852.88M	-
United States of America Growth	-7.68%	-2.82%	24.39%	-	-
Total	5.02B	4.59B	4.29B	3.45B	67.58M
Total Growth	9.30%	7.12%	24.41%	4999.05%	-5.85%

Source: S&P Global Market Intelligence.